The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Serotonin and beyond: therapeutics for major depression
Open accessAbstract
The serotonin (5-HT, 5-hydroxytryptamine) system has been implicated in the pathogenesis of major depressive disorder (MDD). The case for its contribution to the therapeutic efficacy of a wide variety of antidepressant treatments is, however, much stronger. All antidepressant strategies have been shown to enhance 5-HT transmission in the brain of laboratory animals. Catecholamines, norepinephrine (NE) and dopamine (DA) can also play a pivotal role in the mechanism of action of certain antidepressant strategies. The enhancement of 5-HT transmission by selective serotonin reuptake inhibitors, which leads to a dampening of the activity of NE and DA neurons, may account in part for the low remission rate achieved with these medications and/or the residuals symptoms after remission is achieved. The functional connectivity between the 5-HT, NE and DA systems can be used to understand the mechanism of action of a wide variety of augmentation strategies in treatment-resistant MDD. Proof-of-concept studies have shown that antidepressant medications with complementary mechanisms of action on monoaminergic systems can double the remission rate achieved in a trial of standard duration. Novel approaches are also being used to treat MDD, which also appear to involve the monoaminergic system(s) to a varying extent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Grand challenges in global mental health
Collins, P. Y., Patel, V., Joestl, S. S., March, D., Insel, T. R., Daar, A. S., Bordin, I. A., Costello, E. J., Durkin, M., Fairburn, C., et al. (2011) · Nature · doi:10.1038/475027a · Cited by 2,043
Risch, N., Herrell, R., Lehner, T., Liang, K.-Y., Eaves, L., Hoh, J., Griem, A., Kovacs, M., Ott, J., & Merikangas, K. R. (2009) · JAMA · doi:10.1001/jama.2009.878 · Cited by 1,655 · cited 1×
“Although this claim has been challenged [11], the analysis of all 54 studies, instead of subsamples, confirmed this important link [12].”
ResultA functional anatomical study of unipolar depression
Drevets, W., Videen, T., Price, J., Preskorn, S., Carmichael, S., & Raichle, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03628.1992 · Cited by 1,266
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · cited 1×
“The serotonin (5-HT, 5-hydroxytryptamine) hypothesis for depression has been intensely investigated since the 1967 seminal paper of Alec Coppen, laying down the foundation for such a hypothesis [5].”
BackgroundMayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Rush, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1905 · Cited by 870
Social Support, Depression, and Mortality During the First Year After Myocardial Infarction
Frasure-Smith, N., Lespérance, F., Gravel, G., Masson, A., Juneau, M., Talajic, M., & Bourassa, M. G. (2000) · Circulation · doi:10.1161/01.cir.101.16.1919 · Cited by 632
Neuroimaging Abnormalities in the Amygdala in Mood Disorders
DREVETS, W. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07098.x · Cited by 544
de Montigny, C., & Aghajanian, G. K. (1978) · Science · doi:10.1126/science.725608 · Cited by 475
Koller, W. C., Lyons, K., Pahwa, R., & Sf, S. W. (2002) · Cited by 421
Kennedy, S. H., Konarski, J. Z., Segal, Z. V., Lau, M. A., Bieling, P. J., McIntyre, R. S., & Mayberg, H. S. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.778 · Cited by 420
BLIER, P., de MONTIGNY, C., & CHAPUT, Y. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00003 · Cited by 404
Self-citationSerotonergic Neuronal Systems: What Their Anatomic Organization Tells Us about Function
MOLLIVER, M. E. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00002 · Cited by 347
Benkelfat, C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090019003 · Cited by 336
Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1AReceptors
Haddjeri, N., Blier, P., & de Montigny, C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10150.1998 · Cited by 332
Self-citationDeep Brain Stimulation for Psychiatric Disorders
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113638 · Cited by 329
Antidepressant-Like Effects of Medial Prefrontal Cortex Deep Brain Stimulation in Rats
Hamani, C., Diwan, M., Macedo, C. E., Brandão, M. L., Shumake, J., Gonzalez-Lima, F., Raymond, R., Lozano, A. M., Fletcher, P. J., & Nobrega, J. N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.025 · Cited by 324 · cited 2×
“Similar stimulations applied to the equivalent region in the rat brain leads to an enhancement of the firing rate of 5-HT neurons in the dorsal raphe nucleus and an increase in the extracellular levels of 5-HT in the hippocampus [63,64].”
BackgroundChaput, Y., de Montigny, C., & Blier, P. (1986) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00500007 · Cited by 323
Self-citationBlier, P., Ward, H. E., Tremblay, P., Laberge, L., Hébert, C., & Bergeron, R. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020186 · Cited by 316
Self-citationDelgado, P. L., Miller, H. L., Salomon, R. M., Licinio, J., Krystal, J. H., Moreno, F. A., Heninger, G. R., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00014-1 · Cited by 307
Mørk, A., Pehrson, A., Brennum, L. T., Nielsen, S. M., Zhong, H., Lassen, A. B., Miller, S., Westrich, L., Boyle, N. J., Sánchez, C., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189068 · Cited by 271
Ugedo, L., Grenhoff, J., & Svensson, T. H. (1989) · Psychopharmacology · doi:10.1007/bf00442004 · Cited by 267
Chaput, Y., de Montigny, C., & Blier, P. (1991) · PubMed · Cited by 246
Self-citationAdaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
Paul, I. A., Nowak, G., Layer, R. T., Popik, P., & Skolnick, P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38715-x · Cited by 241
Alvarez, E., Perez, V., Dragheim, M., Loft, H., & Artigas, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001027 · Cited by 225
Blier, P., & De Montigny, C. (1983) · The Journal of Neuroscience · doi:10.1523/jneurosci.03-06-01270.1983 · Cited by 223
Self-citationMarek, G. J., & Aghajanian, G. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00945-5 · Cited by 221
Manta, S., Dong, J., Debonnel, G., & Blier, P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0936 · Cited by 217
Self-citationNelson, J. C., Mazure, C. M., Jatlow, P. I., Bowers, M. B., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.007 · Cited by 189
Dremencov, E., Mansari, M. E., & Blier, P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0930 · Cited by 167
Self-citationBlier, P., Gobbi, G., Turcotte, J. E., de Montigny, C., Boucher, N., Hébert, C., & Debonnel, G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.015 · Cited by 161
Self-citationBlier, P., & de Montigny, C. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90107-1 · Cited by 151
Self-citationMenkes, D. B., & Aghajanian, G. K. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90319-8 · Cited by 132
Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects
Delgado, P. L., Charney, D. S., Price, L. H., LANDIS, H. D., & Heninger, G. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90114-8 · Cited by 124
Menkes, D. B., Aghajanian, G. K., & McCall, R. B. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90018-1 · Cited by 122
Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers
Szabo, S. T., De Montigny, C., & Blier, P. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702343 · Cited by 114 · cited 2×
“Long-term administration of SSRIs enhances 5-HT transmission in the locus coeruleus [34].”
BackgroundSelf-citationWest, C. H. K., Ritchie, J., Boss-Williams, K. A., & Weiss, J. M. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009474 · Cited by 110
Wang, R. Y., & Aghajanian, G. K. (1980) · PubMed · Cited by 108
Chernoloz, O., Mansari, M. E., & Blier, P. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.114 · Cited by 106
Self-citationDremencov, E., Mansari, M. E., & Blier, P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.015 · Cited by 101
Self-citationGardner, J., Fornal, C. A., & Jacobs, B. L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00025-0 · Cited by 90
Chenu, F., Mansari, M. E., & Blier, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.140 · Cited by 89
Self-citationBlier, P., & de Montigny, C. (1980) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00504527 · Cited by 88
Self-citationElectroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin.
de Montigny, C. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21545-2 · Cited by 88
Karg, K., Burmeister, M., Shedden, K., & Sen, S. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.189 · Cited by 87
Rapid-acting antidepressant strategies: mechanisms of action
Bunney, B. G., & Bunney, W. E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000927 · Cited by 79
B��que, J.-C., de Montigny, C., Blier, P., & Debonnel, G. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990601)32:3<198::aid-syn6>3.0.co;2-2 · Cited by 73
Self-citationChernoloz, O., Mansari, M. E., & Blier, P. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1611-7 · Cited by 66
Self-citationSeager, M. A., Barth, V., Phebus, L. A., & Rasmussen, K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2198-2 · Cited by 56
Sheehan, D. V., Croft, H. A., Gossen, E. R., Levitt, R. J., Brullé, C., Bouchard, S., & Rozova, A. (2009) · PubMed · Cited by 52
Kawahara, Y., Kawahara, H., Kaneko, F., & Tanaka, M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0826-8 · Cited by 50
Chernoloz, O., Mansari, M. E., & Blier, P. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110038 · Cited by 48
Self-citationChernoloz, O., Mansari, M. E., & Blier, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.18 · Cited by 41
Self-citationGhanbari, R., Mansari, M. E., & Blier, P. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169417 · Cited by 36
Self-citationSequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients
Delgado, P. L., Moreno, F., Onate, L., & Gelenberg, A. J. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002778 · Cited by 35
Ghanbari, R., Mansari, M. E., & Blier, P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2260-1 · Cited by 35
Self-citationCombined catecholamine and indoleamine depletion following response to ECT
Cassidy, F., Weiner, R. D., Cooper, T. B., & Carroll, B. J. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.070573 · Cited by 15
Cited by
Intermittent metabolic switching, neuroplasticity and brain health
Mattson, M. P., Moehl, K., Ghena, N., Schmaedick, M., & Cheng, A. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.156 · Cited by 624
The Roles of Serotonin in Neuropsychiatric Disorders
Pourhamzeh, M., Moravej, F. G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R., Ahadi, R., & Joghataei, M. T. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01064-9 · Cited by 366
Sherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0370-3 · Cited by 295
Serotonin: A never-ending story
Olivier, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.031 · Cited by 253
Reinforcement learning in depression: a review of computational research
Chen, C., Takahashi, T., Nakagawa, S., Inoue, T., & Kusumi, I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.005 · Cited by 233
Metadata
- Authors
- Blier, P., & El Mansari, M.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2013-04-05
- Volume
- 368
- Issue
- 1615
- Pages
- 20120536
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W1974605151
- Cited by
- 257
- References
- 65
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.